CD34 and acute myeloid leukemia: Similar to murine CM-AML cells, human inv(16) AML cells could efficiently uptake miRisten, effectively knocking down miR-126 and resulting in increased apoptosis (Supplementary Fig. 9a–e) and reduced quiescence of inv(16) AML CD34+ cells (Supplementary Fig. 9f, g).